Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity
Carmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing · 2026
Read Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage Atherogenicity by Carmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13255711.txt.
Description
Carmen Hannemann and co-authors report a 2026 laboratory study of iRhom2, a protein that helps macrophages release the inflammatory signal TNF-alpha. Macrophage-driven inflammation starts atherosclerosis, the plaque buildup behind heart attacks and strokes. The team studied macrophages lacking iRhom2 to see what changed.
The altered macrophages still engulfed particles, survived stress, and multiplied normally. They put out less TNF-alpha and more of the calming signal IL-10, though. Fluid from these cells also made blood vessel cells produce fewer of the sticky molecules that recruit more immune cells. The authors suggest blocking iRhom2 could quiet the earliest stage of vessel inflammation while leaving everyday macrophage duties intact, a profile that safer anti-inflammatory strategies would need.
Catalog record
| CREATOR | Carmen Hannemann, Alica Brettschneider, Phillip van Dijck, Karl Stangl, Antje Ludwig, Bernd Hewing |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |